Partnerships & Alliances
Filter News
Found 43,390 articles
-
Sanofi will be responsible for leading the clinical program and funding all studies needed to support the over-the-counter switch in the United States and will also be responsible for the regulatory submissions.
-
Today, Civica Rx announced a five-year deal with London, UK-based Hikma Pharmaceuticals to manufacture and supply Civica’s members with 14 sterile injectable drugs as a private label distributor.
-
Luna Design and Innovation selected as a Channel Partner for Blue Origin
7/23/2019
Luna Design and Innovation Inc., a Toronto-based biotechnology company, announced that it has been selected as an Official Channel Partner for Blue Origin’s New Shepard reusable suborbital rocket system.
-
Raleigh Neurology Associates Brings Specialty Clinical Data Set to the TriNetX Research Network
7/23/2019
Raleigh Neurology Associates, one of the largest private neurology practices in the U.S, has joined the TriNetX global health research network adding a significant new clinical data set to the world's largest research network.
-
Parexel Extends Asia/Pacific Capability with the Launch of Health Advances Asia Limited
7/23/2019
Strategic Healthcare Consulting subsidiary will support development of global expansion strategies for Asia/Pacific and multinational companies from new Hong Kong presence; biopharma and medtech veteran Gary Cheng to lead local team
-
OnKure Executes License and Option Agreement with KDAc Therapeutics
7/23/2019
The collaboration will focus on the continued advancement of KDAc’s lead candidate, KDAc-0001 (or OKI-422), which is licensed from the Broad Institute of MIT and Harvard.
-
Crescendo Biologics’ Second Oncology-targeted Humabody® Licensed by Takeda
7/23/2019
Crescendo Biologics Ltd announces that Takeda Pharmaceutical Company Limited, has exercised a second option under its existing, multi-target collaboration and license agreement.
-
IVERIC bio Announces Successful Advancement of LCA10 Minigene Program and Expansion of Orphan Gene Therapy Portfolio with USH2A-Related Inherited Retinal Diseases Program
7/23/2019
IVERIC bio, Inc. (Nasdaq: ISEE) today announced that the Company has exercised its option and entered into an exclusive global license agreement with the University of Massachusetts Medical School for rights to develop and commercialize mutation independent novel adeno-associated virus (AAV) gene therapy product candidates for the treatment of Leber Congenital Amaurosis type 10 (LCA10) due to mutations to the CEP290 gene, the most common type of LCA.
-
Clinical Research Strategies, LLC Announces Strategic Partnership in Life Science Clinical Development
7/23/2019
Companies to Address Life Sciences Pursuit of Combination Drug or Device with Digital Health, Digital Therapeutics, Blockchain, and Software as a Medical Device Platform in Clinical Development
-
Uman Diagnostics And Bio-Techne Announce License And Supply Agreement For Neurofilament Light Assay
7/23/2019
Under the terms of the agreement, Uman Diagnostics will supply Nf-L antibodies to Bio-Techne for use in its proprietary Simple Plex™ immunoassays on Ella.
-
Hikma and Civica Rx sign long-term agreement to reduce generic drug shortages in the US
7/23/2019
Partnership will supply 14 essential medicines to US hospitals and patients
-
Pharmacy Times® Adds the Community Oncology Pharmacy Association to Its Strategic Alliance Partnership Program
7/23/2019
The partnership will develop and publish Directions in Oncology PharmacyTM
-
Xylyx Bio joins Advanced Regenerative Manufacturing Institute (ARMI) Consortium
7/23/2019
Xylyx Bio, a pioneer in physiomimetic biomaterials, today announced that it has joined the Advanced Regenerative Manufacturing Institute (ARMI), a public-private Manufacturing USA initiative that supports the manufacturing of engineered tissues and tissue-related technologies.
-
BostonGene Announces Partnership with National Institutes of Health
7/23/2019
Precision Medicine Studies Underway to Enable Dynamic Monitoring of Disease Progression and Response to Treatment
-
SnapMD Partners with Carefluence to Deliver Enterprise-Level Virtual Care Management Telemedicine Platform
7/23/2019
Carefluence offers SnapMD's VCM telemedicine software as a comprehensive clinical care solution to virtually connect providers to patients and their existing EHRs
-
Pack Health and Glooko Partner to Integrate Blood Glucose Monitoring with Digital Health Coaching Services
7/23/2019
Digital health coaching platform Pack Health today announced a new partnership with Glooko, the leader in diabetes data management and visualization, to augment diabetes health coaching and care coordination services with remote real time data for blood glucose control.
-
Premier’s ProvideGx™ Program to Supply Sodium Bicarbonate Injection to Providers
7/23/2019
Premier Inc., through its ProvideGx™ program, has partnered with Exela Pharma Sciences, LLC, to supply sodium bicarbonate injection to healthcare providers, a drug that has been in shortage in the U.S. for nearly two years.
-
University of Puerto Rico Joins Caris Life Sciences' Precision Oncology Alliance
7/23/2019
Puerto Rico's primary healthcare and medical research institution becomes the 28th member of Caris' collaborative network dedicated to making cancer treatment more precise and effective.
-
“We are pleased to be working on this program with Gilead given their expertise and global leadership in the HIV and HBV fields,” stated James E. Brown, president and chief executive officer of DURECT.
-
ADL Bionatur Solutions and Amyris Inc. Expand Contract to 2020
7/22/2019
ADL Bionatur Solutions (MAB: ADL), a company specialized in research and development of sustainable health and beauty products, services and industrial fermentation production, announces the expansion of its existing production agreement with Amyris, Inc.